华安国证生物医药ETF发起式联接A(012598)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
90,121,100 |
104,812,000 |
43,516,200 |
28,824,900 |
14,691,300 |
16.3% |
2023/12/31 |
82,667,100 |
90,121,100 |
61,424,200 |
53,970,200 |
7,454,000 |
9.02% |
2023/12/31 |
87,113,300 |
90,121,100 |
40,661,700 |
37,653,800 |
3,007,900 |
3.45% |
2023/9/30 |
82,667,100 |
87,113,300 |
20,762,600 |
16,316,400 |
4,446,200 |
5.38% |
2023/8/13 |
33,243,000 |
82,667,100 |
83,384,800 |
33,960,600 |
49,424,200 |
148.68% |
2023/8/13 |
61,617,500 |
82,667,100 |
34,049,200 |
12,999,600 |
21,049,600 |
34.16% |
2023/6/30 |
33,243,000 |
61,617,500 |
49,335,500 |
20,961,000 |
28,374,500 |
85.35% |
2023/6/30 |
32,695,600 |
61,617,500 |
42,628,700 |
13,706,800 |
28,921,900 |
88.46% |
2023/3/31 |
33,243,000 |
32,695,600 |
6,706,790 |
7,254,190 |
-547,400 |
-1.65% |
2022/12/31 |
22,109,300 |
33,243,000 |
24,657,400 |
13,523,600 |
11,133,800 |
50.36% |
2022/12/31 |
26,093,200 |
33,243,000 |
11,137,700 |
3,987,880 |
7,149,820 |
27.4% |
2022/9/30 |
24,651,300 |
26,093,200 |
4,806,330 |
3,364,500 |
1,441,830 |
5.85% |
2022/6/30 |
22,109,300 |
24,651,300 |
8,713,310 |
6,171,240 |
2,542,070 |
11.5% |
2022/6/30 |
23,944,700 |
24,651,300 |
3,394,850 |
2,688,190 |
706,660 |
2.95% |
2022/3/31 |
22,109,300 |
23,944,700 |
5,318,460 |
3,483,040 |
1,835,420 |
8.3% |
2021/12/31 |
18,762,300 |
22,109,300 |
8,289,170 |
4,942,250 |
3,346,920 |
17.84% |
2021/12/31 |
19,053,200 |
22,109,300 |
6,848,170 |
3,792,110 |
3,056,060 |
16.04% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。